Overview
Rare peripheral precocious puberty in females is an uncommon form of precocious puberty in which the early development of secondary sexual characteristics is driven by sex steroid production independent of the hypothalamic-pituitary-gonadal (HPG) axis. Unlike central precocious puberty, where premature activation of the HPG axis triggers puberty, peripheral precocious puberty (also called gonadotropin-independent precocious puberty) results from autonomous estrogen secretion from sources such as ovarian cysts, ovarian tumors (e.g., granulosa cell tumors), adrenal tumors, or exogenous estrogen exposure. In females, this can manifest as breast development (thelarche), vaginal bleeding, accelerated linear growth, and advanced bone age occurring before the age of 8 years. The condition primarily affects the reproductive and endocrine systems. Clinical evaluation typically reveals suppressed gonadotropin levels (LH and FSH) with elevated estradiol, distinguishing it from central precocious puberty. Imaging studies such as pelvic ultrasound and adrenal imaging are essential to identify the underlying cause. Rare genetic conditions such as McCune-Albright syndrome (caused by somatic activating mutations in the GNAS gene) can also present with peripheral precocious puberty in girls due to autonomous ovarian function. Treatment depends on the underlying etiology. Surgical removal of hormone-secreting tumors may be curative. For conditions like McCune-Albright syndrome, aromatase inhibitors (such as letrozole) or selective estrogen receptor modulators (such as tamoxifen) have been used to manage estrogen excess. Monitoring of growth velocity, bone age, and pubertal progression is essential. If peripheral precocious puberty triggers secondary central precocious puberty, GnRH agonist therapy may also be required. Early diagnosis and management are important to prevent psychosocial distress and to optimize adult height potential.
Variable
Can be inherited in different ways depending on the underlying gene
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Rare peripheral precocious puberty in female.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Rare peripheral precocious puberty in female at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Rare peripheral precocious puberty in female.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Rare peripheral precocious puberty in female.
Community
No community posts yet. Be the first to share your experience with Rare peripheral precocious puberty in female.
Start the conversation →Latest news about Rare peripheral precocious puberty in female
No recent news articles for Rare peripheral precocious puberty in female.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Rare peripheral precocious puberty in female
What is Rare peripheral precocious puberty in female?
Rare peripheral precocious puberty in females is an uncommon form of precocious puberty in which the early development of secondary sexual characteristics is driven by sex steroid production independent of the hypothalamic-pituitary-gonadal (HPG) axis. Unlike central precocious puberty, where premature activation of the HPG axis triggers puberty, peripheral precocious puberty (also called gonadotropin-independent precocious puberty) results from autonomous estrogen secretion from sources such as ovarian cysts, ovarian tumors (e.g., granulosa cell tumors), adrenal tumors, or exogenous estrogen
At what age does Rare peripheral precocious puberty in female typically begin?
Typical onset of Rare peripheral precocious puberty in female is childhood. Age of onset can vary across affected individuals.